SOLBORN Increases Stake in INFINITT Healthcare from 50.29% to 51.80% – Strengthening Control via Open Market Purchases
SOLBORN, the largest shareholder of INFINITT Healthcare, increased its stake from 50.29% to 51.80% through open market purchases, a 1.51 percentage point rise.
The purchases were made by SOLBORN and its specially related parties Kinemaster and R.A.G., acquiring a total of 367,326 shares for approximately 2.67 billion KRW using internal corporate funds.
No new shares were issued and no dilution occurred, reinforcing the controlling shareholder's commitment to the company.
[AI Summary]The stake increase signals enhanced governance stability, but without additional shareholder return measures, short-term price catalysts remain limited. Investors should monitor the balance between control stability and growth strategy execution.